Experience
Stryker Corporation
Genetics Institute
The PTO initiated an interference between a patent application of Finnegan client Genetics Institute and a patent of Stryker Corporation. The PTO awarded judgment to Genetics Institute, thus resolving priority of invention to the disputed subject matter. The interference related to bone morphogenic proteins, which affect bone growth.
Stryker Corporation v. Genetics Institute, Int. No. 105508, PTAB, Judges McKelvey, Nagumo, Schafer
Finnegan secures an award of priority in transdermal drug delivery interference
Minnesota Mining and Manufacturing Co.
Interference victory for inventors of electrosurgical scissors
Boston Scientific
Resolving an appropriate standard for what Is “material” information in patent prosecution
Digital Control, Inc.
Institut Pasteur
Alliance for Sustainable Energy, LLC
Geron Corp.
LG Electronics Inc.
Finnegan trade secret case resolved with favorable summary judgment for client RichWave
RichWave Technology Corporation
Abbott Vascular
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.